Effect of Intensive Fly Control on Trachoma and Ocular Chlamydia Infection in Tanzania
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT00347763 |
|
Recruitment Status :
Completed
First Posted : July 4, 2006
Last Update Posted : April 15, 2013
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Trachoma | Procedure: 10% permethrin in water applied as low volume spray | Phase 4 |
Trachoma is the leading infectious cause of blindness in the world. The World Health Organization (WHO), recognizing the important public health impact of trachoma, has adopted a resolution to eliminate blinding trachoma by the year 2020 (3). In order to accomplish this ambitious goal, WHO recommends the use of "SAFE" strategy for countries implementing trachoma control programs. This multi-faceted approach includes Surgery for trichiasis cases, Antibiotics to treat the community pool of infection, Face washing to reduce transmission, and Environmental change.
The environmental change component currently rests largely on efforts to reduce the fly populations in these communities. A pilot study and clinical trial using intense insecticide spraying reduced both flies and trachoma in a trachoma hypo-endemic area of The Gambia. In The Gambia setting, flies appear to be an important vector for trachoma, but it is not clear that flies are equally important in areas with hyper-endemic trachoma, nor is it known if fly control adds value to the provision of mass antibiotic treatment for active trachoma as part of the SAFE strategy.
The purpose of this community-based randomized trial was to determine, in trachoma hyper-endemic communities of Tanzania, the added value of intensive spraying to control flies on the fly population and on trachoma and ocular C. trachomatis infection at 6 months and one year after mass antibiotic treatment. Neighborhoods with intensive spraying (Intervention) and neighborhoods with no spraying (control) all received mass antibiotic treatment with azithromycin immediately prior to the start of the study, enabling us to evaluate the additional impact of fly control on trachoma.
Kongwa district in central Tanzania has been shown to have a high prevalence of active trachoma, and was chosen as the site of this study. We randomized sixteen balozi to receive either mass treatment with azithromycin alone (control), or mass treatment plus an intensive fly spraying program (intervention). Pre-school aged children are the reservoirs of infection and disease within these communities. Therefore, within each balozi, all children aged less than eight served as sentinel markers for the status of trachoma at baseline, 6 months, and one year after baseline. In the eight intervention balozi, 119 children from 87 families were enrolled at baseline, and in the eight control balozi, 183 children from 145 families were enrolled.
The balozis were surveyed and an area surrounding the intervention balozis was targeted for insecticide spray. A solution of 10% permethrin in water was used with a Hudson and MicronAir sprayer machines, At the outset, spraying was carried out every two days for two weeks (attack phase) then once per week (maintenance phase) for the rest of the study.
Two sticky traps, fly paper strips were placed in each balozi to capture flies. The traps were changed every week, and the number of flies captured were counted. If the average number in the intervention balozis exceeded 25% of that in the control balozis, an attack phase, as described above, was reinstituted to keep the fly population low in the intervention group.
The primary outcome was the prevalence of trachoma in the pre-school aged children at 6 months and one year post mass antibiotic treatment.Outcomes are reported based on masked photographic gradings. Secondary outcome was ocular C. trachomatis infection, based on use of Amplicor C. trachomatis qualitative PCR assay.
comparison: Balozi randomized to receive intensive fly spray intervention,compared to Balozi with no fly spray intervention
| Study Type : | Interventional (Clinical Trial) |
| Enrollment : | 350 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Single (Outcomes Assessor) |
| Primary Purpose: | Prevention |
| Official Title: | Strategies for the Control of Blinding Trachoma: Effect of Fly Spray |
| Study Start Date : | June 2000 |
| Actual Primary Completion Date : | September 2002 |
| Actual Study Completion Date : | October 2002 |
| Arm | Intervention/treatment |
|---|---|
|
No Intervention: control
no active fly spray intervention
|
|
|
Active Comparator: intervention
aerial spray of permethrin daily for two weeks and weekly as needed by assessment of fly density
|
Procedure: 10% permethrin in water applied as low volume spray |
- clinical trachoma [ Time Frame: 1 year ]clinical grading of conjunctival photographs for follicular trachoma
- ocular C. trachomatis infection [ Time Frame: 6 months ]laboratory assessment of chlamydial DNA on ocular swab; measured as present or absent
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 12 Months to 8 Years (Child) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Balozi in Chiwe area
- Sentinel children: age less than 8 years
Exclusion Criteria:
- Balozi in Chiwe without geographic borders
- Sentinel children:age more than 8 years
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00347763
| United States, Maryland | |
| Johns Hopkins University/ Kongwa Trachoma Project | |
| Baltimore, Maryland, United States, 21205 | |
| Principal Investigator: | Sheila West | Johns Hopkins University |
Publications of Results:
| ClinicalTrials.gov Identifier: | NCT00347763 History of Changes |
| Other Study ID Numbers: |
WellcomeTrust 059134 |
| First Posted: | July 4, 2006 Key Record Dates |
| Last Update Posted: | April 15, 2013 |
| Last Verified: | May 2004 |
Keywords provided by Johns Hopkins University:
|
trachoma chlamydia flies permethrin |
Additional relevant MeSH terms:
|
Trachoma Conjunctivitis, Bacterial Eye Infections, Bacterial Bacterial Infections Chlamydia Infections Chlamydiaceae Infections Gram-Negative Bacterial Infections Eye Infections |
Infection Conjunctivitis Conjunctival Diseases Eye Diseases Corneal Diseases Permethrin Enzyme Inhibitors Molecular Mechanisms of Pharmacological Action |